Navigation Links
Patient Self-Monitoring: Devices, Markets, Players and Prospects
Date:12/2/2013

DUBLIN, December 2, 2013 /PRNewswire/ --

Research and Markets ( http://www.researchandmarkets.com/research/rpsc3g/patient) has announced the addition of the "Patient Self-Monitoring: Devices, Markets, Players and Prospects" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring has until recently been performed in physician offices or similar healthcare settings.

The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of conditions from caregiver facilities and into homes. In the process, patient self-monitoring for cholesterol, INR and hypertension have the potential to transition from a cottage industry into a significant market. The key enabler of this significant shift will be technological advances that will provide accurate readings in a format that consumers can understand, clearly indicating when a follow-up visit to a caregiver is needed. Systems that allow patients to share readings with physicians electronically have already been introduced. Ultimately, the success of this self-test market will rely on monitors that can provide accurate values for the various analytes that are associated with health risk, presenting them to the patient in the proper context.


Highlights

- Analyzes and evaluates self-test monitoring technologies and products, and assesses the market potential, commercialization risks and opportunities

- Examines next-generation monitor technologies, design issues and evolving market factors

- Provides forecasts and market data for self-monitoring products to 2018

- Assesses the impact and influence of self-monitoring enhancements on the healthcare management market

- Profiles self-monitoring market participants, their technology, product development activity, and business strategies

Key Topics Covered


Disease Management Market Dynamics

  • Patient Monitoring Overview
  • Key Factors in Patient Compliance
  • Market Drivers
  • Shifting Patient Demographics
  • Industry Alignment and Competitive Landscape


Self-Monitoring Technology Strategies

  • Needle-Stick Tests
  • Self-Collected / Mail-in Tests
  • Combination Meters
  • Continuous Monitors
  • Future Developments
  • Noninvasive Monitors
  • Signal Processing Advances


Monitor Product Design & Patient Issues

  • Reliability
  • Measurement Frequency
  • Patient/User Interface
  • Measurement Electronics
  • Calibration
  • Accuracy/Precision
  • Sensitivity
  • Sensor Technology


Self-Monitoring Therapeutic Segments

  • Atherosclerosis/Heart Disease (Cholesterol)
  • Diabetes (Glucose)
  • Heart Valve Replacement/Thrombosis
  • Hypertension (Blood Pressure)


Self-Monitoring Product Segment Analysis

  • Cholesterol Monitors
  • Coagulation Monitoring
  • Glucose Monitors
  • Traditional Meters
  • Continuous Monitors
  • Noninvasive Glucose Monitors
  • Combination Monitors
  • Hypertension
  • Potential/Emerging Self-Monitoring Segments


Market Factors

  • Clinical Trial Issues
  • Regulations and Guidance
  • Managed care/Reimbursement
  • Patient Compliance
  • Sourcing/Private Labeling


Patient Self-Monitoring - Company Profile

For more information visit http://www.researchandmarkets.com/research/rpsc3g/patient

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Watching, Reading and Listening: A New Way to Interact with Patient Information
4. Phreesia identifies over 26% of patients who require additional autism evaluation
5. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
8. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
9. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Multiple Myeloma Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Multiple Myeloma epidemiology, Multiple Myeloma market valuations ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Actinic Keratosis Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Actinic Keratosis epidemiology, Actinic Keratosis market valuations ...
(Date:5/3/2016)... , May 3, 2016 BioNovus Innovations ... Institute for Advancing Medical Innovation (IAMI) today announced ... drugs, diagnostics and medical devices. An ... with rights to license, develop and commercialize medical ... "This partnership represents a significant advance ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... Chronic stress can have a ... it can weaken the immune system and increase inflammation, both of which raise the ... the adult congenital heart disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also ...
(Date:5/5/2016)... Texas (PRWEB) , ... May 05, 2016 , ... ... relationship-marketing firm, honored finalists and winners Tuesday evening, May 3, at the 2016 ... Texas. , Scott Pettigrew, Vice President and Chief Security Officer of HMS, ...
(Date:5/5/2016)... ... ... If you don’t mind a bit of prickly therapy to help combat acne ... treatment that some have called the next great tool in dermatology – microneedling, says ... skin needling, is a procedure using a device covered with tiny, shallow needles to ...
(Date:5/5/2016)... ... May 05, 2016 , ... Pigment Laser Tattoo Removal Center is ... of the new PiQo4™ laser, the first 4-wavelenth picosecond laser to receive FDA Clearance. ... other picosecond laser on the market. Jeremy Miller, Tattoo Artist and former reality ...
(Date:5/5/2016)... GA (PRWEB) , ... May 05, 2016 , ... Liposuction ... (FDRS) 2016 Conference in St. Louis, Missouri at the Marriot St. Louis Airport Hotel. ... Byrd was chosen to address the conference about her unique specialization in treating Lipedema. ...
Breaking Medicine News(10 mins):